GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

COVID-19 spike clouds US vehicle market outlook, says GlobalData

Following news that COVID-19 cases are on the rise in a number of US States, prompting new restrictions on populations; Calum MacRae, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “Rising COVID-19 cases in the US brings further downside to GlobalData’s US light vehicle sales forecast. Increasing infection rates in […]
Read more

Discussions on COVID-19 and the use of telehealth and telemedicine by digital pharma influencers peaked in March, says GlobalData

The number of social media posts made by digital pharma influencers related to COVID-19 has increased significantly since it was declared a pandemic in March, but content specifically discussing telehealth and telemedicine seems to have peaked in March, says GlobalData, a leading data and analytics company. According to GlobalData’s Digital Pharma Influencer database, there were […]
Read more

High number of social media posts about COVID-19 and asthma by immunology influencers since February, says GlobalData

Since COVID-19 was declared a pandemic in March 2020, social media posts related to the virus from immunology influencers increased significantly, with content peaking in March, says GlobalData, a leading data and analytics company. According to GlobalData’s Immunology Influencer database, there were only 2 and 19 COVID-19 posts, respectively, from immunology influencers in January and […]
Read more

Social media posts about COVID-19 and stroke by neurology influencers peaked in April, says GlobalData

Since COVID-19 was declared a pandemic in March 2020, social media posts related to the virus from neurology influencers increased significantly, with content peaking in April, says GlobalData, a leading data and analytics company. According to GlobalData’s Neurology Influencer database there were only three COVID-19 posts made by neurology influencers for both January and February, […]
Read more

COVID-19 not only reason for Apple and Huawei’s decelerating phone revenue growth, says Globaldata

While supply chain disruptions and retail store closures due to COVID-19 lockdowns in early 2020 have impacted smartphone revenues, other factors such as post-holiday seasonality, slowing phone upgrade rates and geopolitics have played a part on their bottom line, says GlobalData, a leading data and analytics company. Anisha Bhatia, Senior Analyst at GlobalData, comments: “The […]
Read more

Gilead’s remdesivir faces pricing and generic challenges, says GlobalData

There are concerns over the pricing of remdesivir and how to make it available in low-income and lower-middle income countries, says GlobalData, a leading data and analytics company. Historically, intravenously (IV) administered drugs come with a large price tag, but pharmaceutical companies are facing pressure to forego profits in exchange for reputation gains and goodwill. […]
Read more

Telemedicine expected to be used at high levels after the COVID-19 crisis, with most potential in chronic disease management, says GlobalData

A total *76% of people, as surveyed by GlobalData, expect telemedicine to be used widely once the pandemic had abated. Kathryn Whitney, MSc, Director of Thematic Analysis, comments: “Telemedicine offers patients better access to care, improved health outcomes and increased patient empowerment. For healthcare professionals, it allows high-risk patients to be monitored and treated more […]
Read more

COVID-19 to boost healthcare wearables uptake, but consumer protection concerns remain, says GlobalData

The health and fitness wearables that monitor physiological parameters such as heart rate, body temperature, sleeping patterns, blood pressure and oxygen saturation levels may become an effective early-warning system to detect COVID-19 if regulatory, safety and consumer protection requirements are addressed, says GlobalData, a leading data and analytics company. Urte Jakimaviciute MSc, Senior Director of […]
Read more
1 50 51 52 53 54 77